Wockhardt gets GMP Compliance Certificate for manufacturing unit in Ankleshwar

23 Aug 2019 Evaluate

Wockhardt has received GMP Compliance Certificate from French National Agency for Medicines and Health Products Safety for its manufacturing Unit at Ankleshwar, Gujarat. The manufacturing facility complies with the principles of Good Manufacturing Practices for active substances.

This is reflected in the Eudra GMDP database. The said GMP Compliance Certificate is valid for a period of 3 years i.e. upto April 2, 2022. EudraGMDP is the name of the European Union database which inter-alia contains Good Manufacturing (GMP) Certificates.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1352.00 -6.95 (-0.51%)
18-Dec-2025 10:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1754.50
Dr. Reddys Lab 1267.80
Cipla 1498.30
Zydus Lifesciences 916.70
Lupin 2111.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×